Scilex Holdings Invests $20M in Quantum Scan to Expand Non‑Opioid Pain & Diagnosis Markets
Scilex Holding Company boosts its biopharma reach with a $20 M Quantum Scan investment, expanding non‑opioid pain solutions amid volatile biotech markets.
2 minutes to read
